Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Maastricht University Medical Center
With
AstraZeneca
Age
5–18
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Asthmatic and control children, aged 5 to 16 years
Children with doctor-diagnosed asthma, known at the department of Paediatric Pulmonology, University Hospital Maastricht
You may not be if
Presence of a disease that might interfere with the results of this study (e.g. recent upper airway infection, heart disease, anatomic abnormalities of the airways and other chronic inflammatory diseases such as Crohns disease and rheumatoid arthritis)
Mental retardation
Inability to perform the EBC procedure properly
Active smoking
The use of one of the following medication: Papaverin, Sodium nitroprusside, ACE inhibitors, Oxymetazoline, L-arginine, or NOS inhibitors
Clareo Health | Inflammatory Markers in Exhaled Breath (Condensate) in Childhood Asthma
